沪深两市成交额高达2.55万亿，较上一个交易日放量5011亿。 1月5日，A股主要指数集体高开后震荡走强，沪指时隔34个交易日重回4000点。截至收盘，沪指涨1.38%，深成指涨2.24%，创业板指涨 2.85%。科创综指涨3.61%。 | | | 【资金流向】 主力资金全天净流入电子、医疗器械、保险等板块，净流出通信、航天航空、光伏设备等板块。 具体到个股来看，胜宏科技、兆易创新、贵州茅台获净流入19.40亿元、16.52亿元、10.26亿元。 净流出方面，航天电子、中国卫星、航天发展遭抛售20.34亿元、17.08亿元、14.09亿元。 | 代码 | 名称 | 两日图 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | | 000001 | 上证指数 | www | 4023.42c | 54.58 | 1.38% | | 399001 | 深证成指 | 5 | 13828.63c | 303.61 | 2.24% | | 399006 | 创业板指 | S | 3294.55c | 91.38 | 2.85% | | 000680 | 科创综指 ...

Market Overview - The A-share market opened strongly in 2026, with the ChiNext index leading the gains and the Shanghai Composite Index returning above 4000 points, marking a twelve-day consecutive rise [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion yuan, an increase of 501.1 billion yuan compared to the previous trading day [1] Sector Performance - The brain-computer interface sector was the top performer, with over thirty constituent stocks hitting the daily limit, including Sanbo Brain Science, Meihao Medical, and Innovation Medical [1] - The insurance sector saw significant gains, with New China Life Insurance and China Pacific Insurance reaching new historical highs [1] - The commercial aerospace sector remained active, with companies like Reco Defense achieving four consecutive limit-ups and China Satellite Communications hitting three limit-ups in five days [1] - The semiconductor industry chain showed strength, with stocks like Yaxiang Integration and Shenghui Integration also hitting the daily limit [1] - The AI application sector was notably active, with BlueFocus Media achieving two consecutive limit-ups [1] Declines - The Hainan Free Trade Zone concept experienced a collective decline, with Hainan Development hitting the daily limit down [2]

Market Overview - The market opened positively on January 5, 2026, with the ChiNext Index leading the gains, and the Shanghai Composite Index returning above 4000 points, marking a twelve-day consecutive rise [1] - The Shanghai Composite Index increased by 1.38%, the Shenzhen Component Index rose by 2.24%, and the ChiNext Index surged by 2.85% [1][2] - The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion yuan, an increase of 501.1 billion yuan compared to the previous trading day [1][5] Index Performance - Shanghai Composite Index closed at 4023.42, with a rise of 1.38% and 1772 gainers against 501 losers [2] - Shenzhen Component Index closed at 13828.63, up by 2.24%, with 2237 stocks rising and 628 falling [2] - ChiNext Index ended at 3294.55, increasing by 2.85%, with 1136 stocks gaining and 239 losing [2] Market Activity - Over 4100 stocks in the market experienced gains, with 127 stocks hitting the daily limit up [2][4] - Key sectors showing strong performance included brain-computer interface concepts, insurance, commercial aerospace, semiconductor industry, and AI applications [2] - Notable stocks included Sanbo Brain Science, Meihao Medical, and Innovation Medical, all hitting the daily limit up [2] Sector Highlights - The brain-computer interface sector led the market, with over thirty stocks reaching the daily limit up [2] - The insurance sector saw significant gains, with Xinhua Insurance and China Pacific Insurance reaching new historical highs [2] - The commercial aerospace sector remained active, with stocks like Reco Defense and China Satellite Communications showing strong performance [2] Trading Statistics - The limit-up rate was recorded at 81%, with a high opening rate of 56% and a profit rate of 67% [6] - The market saw 4185 stocks rising, 1168 stocks falling, and 12 stocks suspended [4]

Market Performance - The A-share market opened positively on the first trading day of 2026, with all three major indices significantly rising. The Shanghai Composite Index (SSE) recorded a 12-day winning streak, returning to the 4000-point mark, closing at 4023 points, up 1.38%. The Shenzhen Component Index rose 2.24%, and the ChiNext Index increased by 2.85% [1] - The total market turnover reached 2.57 trillion yuan, an increase of 501.5 billion yuan compared to the previous trading day, with nearly 4200 stocks rising [1] Sector Performance - The brain-computer interface sector surged following Elon Musk's plan for large-scale production of brain-machine interface devices, leading to a wave of limit-up stocks including Daosheng Technology, Sanbo Brain Science, and Lepu Medical [1] - Insurance stocks experienced significant gains, with Xinhua Insurance rising over 8% [1] - The medical device sector also saw an uptick, with companies like Sainuo Medical hitting their daily limit [1] - AI chip and memory chip sectors rallied, with stocks such as Purun Co. and Hengshuo Co. reaching their daily limit [1] - Other sectors with notable gains included recombinant proteins, Kuaishou concepts, CRO, gaming, and Sora concepts [1] - Conversely, the Hainan and duty-free sectors declined, with Haikou Group and Hainan Development leading the losses. The tourism and hotel sector also fell, with Caesar Travel dropping nearly 7% [1] - The railway, highway, electric machinery, and airport sectors were among those with the largest declines [1] Fund Flow and Performance Rankings - The top sectors by net capital inflow over the past five days included insurance (+6.20%), healthcare (+5.46%), and internet (+4.44%) [2] - Other sectors with notable five-day gains included biotechnology (+3.92%), semiconductors (+4.01%), and computer hardware (+3.75%) [2]

Market Performance - The market opened strong on January 5, 2026, with the ChiNext Index leading the gains, and the Shanghai Composite Index returning above 4000 points, marking a twelve-day winning streak [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion, an increase of 501.1 billion compared to the previous trading day [1] - The Shanghai Composite Index rose by 1.38%, the Shenzhen Component Index increased by 2.24%, and the ChiNext Index gained 2.85% [1] Sector Highlights - The brain-computer interface concept led the market, with over thirty constituent stocks hitting the daily limit, including Sanbo Brain Science, Meihao Medical, and Innovation Medical [1] - The insurance sector saw significant gains, with Xinhua Insurance and China Pacific Insurance reaching new historical highs [1] - The commercial aerospace concept was actively traded, with LeiKe Defense achieving four consecutive limit-ups and China Satellite Communications hitting three limit-ups in five days [1] - The AI application concept also performed well, with BlueFocus Media achieving two consecutive limit-ups [1] Declines - The Hainan Free Trade Zone concept experienced a collective decline, with Hainan Development hitting the daily limit down [1]

Market Performance - The A-share market experienced a "good start" on the first trading day of the new year, with the Shanghai Composite Index rising over 1% and surpassing the 4000-point mark [1] - The technology growth sector led the gains, particularly in the electronics and pharmaceutical biotechnology sectors, with multiple stocks hitting the daily limit [3] - Non-bank financial sectors, especially insurance stocks, also showed strong performance, while sectors like oil and banking experienced adjustments [3] Brain-Computer Interface Sector - The brain-computer interface (BCI) concept sector performed exceptionally well, with stocks like BeiYikang hitting a 30% limit up, and several others, including BoTuo Bio and Sanbo Neuroscience, reaching 20% limit up [3] - Elon Musk announced plans for large-scale production of BCI devices by his company Neuralink, which aims to streamline surgical processes and enhance device control capabilities [3] - Domestic companies are actively engaging in BCI business, with Meihao Medical collaborating with BCI clients, and Xiangyu Medical planning to expand its BCI project to over 700 medical institutions by early 2026 [4] Company Developments - Meihao Medical indicated that artificial cochlear implants are a significant application direction for BCI, although current revenue from this business is still small [4] - Xiangyu Medical aims to establish a comprehensive product matrix for BCI by entering over 1000 top-tier hospitals within the year [4] - Entropy Technology is focusing on developing next-generation BCI algorithms and advancing hybrid biometric recognition and brain signal analysis [4] Hong Kong Market Activity - In the Hong Kong market, BCI-related stocks also showed significant activity, with Nanjing Panda Electronics rising over 40% and other stocks like Micro-Innovation Brain Science experiencing substantial gains [4]

随着马斯克明确给出脑机接口设备的量产时间表，这一前沿赛道正从实验室的科学探索加速走向商业化落地，行业或将迎来从"医疗试验品"向"大 众消费品"跨越的关键转折点。 2026年A股开盘首日，脑机接口板块表现强势。倍益康30CM涨停，三博脑科、翔宇医疗、美好医疗、爱朋医疗、诚益通、伟思医疗等多股20CM 涨停，市场资金对脑机接口商业化前景展现出极高预期。 | 代码 | 名称 | 现价 | 涨跌幅 ▼ | 涨跌 | 换手率 | | --- | --- | --- | --- | --- | --- | | 688108 | 賽诺医疗 | 23.09 | 20.01% | 3.85 | 14.83% | | 300238 | 冠昊生物 | 16.62 | 20.00% | 2.77 | 13.53% | | 300753 | 爰朋医疗 | 33.30 | 20.00% | 5.55 | 21.10% | | 301363 | 美好医疗 | 28.86 | 20.00% | 4.81 | 1.93% | | 688626 | 翔宇医疗 | 72.60 | 20.00% | 12.10 | 3.36% | | 300003 ...

Core Viewpoint - The brain-computer interface (BCI) industry is experiencing rapid growth, driven by advancements in technology and supportive government policies, with significant developments expected by 2026 when large-scale production is set to begin [2][3]. Industry Developments - Neuralink plans to start mass production of BCI devices in 2026, utilizing nearly fully automated surgical processes [2]. - The BCI index in the A-share market rose by 9.37%, with over 20 stocks, including companies like Botao Bio and Sanbo Brain Science, hitting the daily limit [2]. - The National Healthcare Security Administration (NHSA) has issued guidelines for BCI rehabilitation charges, which has accelerated the industry's growth [2]. Policy Support - The 14th Five-Year Plan identifies BCI as one of six key future industries, with specific pricing projects established for both invasive and non-invasive BCI technologies [3]. - New regulations from the NHSA in September 2025 will facilitate the coding of innovative medical products, further promoting BCI clinical applications [3]. Technological Breakthroughs - China has made significant strides in invasive BCI technology, becoming the second country globally to enter clinical trials for invasive BCI systems [4]. - The "North Brain No. 1" GCP multi-center clinical trial, set to launch in October 2025, will be the first to implement a high-throughput, wireless, semi-invasive BCI system with over 100 channels [4]. Competitive Landscape - The BCI industry in China is competitive, with the potential to lead globally, as companies focus on serving downstream clients, including hospitals and patients [5]. - The BCI industry has established a complete supply chain, covering upstream materials and chips, midstream signal processing, and downstream applications in healthcare and consumer products [6]. Regulatory Focus - BCI products, especially invasive types, are classified as high-risk medical devices, necessitating strict regulatory oversight [8]. - Companies like Xiangyu Medical and Aipeng Medical are actively pursuing product registrations for various BCI applications, including rehabilitation and monitoring systems [8][9].

1月5日，脑机接口板块领涨A股。截至发稿，板块涨幅超13%，个股方面，倍益康30CM涨停，三博脑 科、博拓生物、美好医疗、翔宇医疗等近20股涨停。 消息面上，马斯克日前在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接口设备 进行"大规模生产"，并转向"更加精简和几乎完全自动化的外科手术流程"。其最新技术的设备电极丝可 直接穿过硬脑膜，而无需将其切开。 据悉，Neuralink的产品重点仍集中在治疗神经系统疾病，包括瘫痪、肌萎缩、帕金森、老年痴呆和视力 障碍。 同时，国内医疗企业在该领域不断实现技术突破。三博脑科旗下的福建三博已帮助受试者偏瘫上肢恢复 自由抓握功能；"北脑二号"也有望在2026年进入临床验证。博拓生物参股公司的植入式脑深部神经刺激 系统已进入科研性临床，产品拟2026年末启动注册。 不仅如此，资本市场对该领域的投资也较为火热，据动脉橙数据库不完全统计，2025年1—11月，我国 脑机接口领域共完成24起融资，同比增长30%。 中信建投在研报中分析称，脑机接口是医疗投资也是科技投资，短期来看主要应用于疾病治疗，长期来 看若能实现增强人、并与AI和机器人融合，有望打开万亿 ...

截至2026年1月5日 14:14，中证全指医疗保健设备与服务指数(H30178)上涨5.00%，样本股博拓生物 (688767)上涨20.01%，赛诺医疗(688108)上涨20.01%，三博脑科(301293)上涨20.01%，迈普医学 (301033)，美好医疗(301363)等个股均上涨。 近日，马斯克在社交媒体上表示，他的脑机接口公司Neuralink今年将开启"大规模量产"，推进全自动化 外科手术流程，让曾经的科幻黑科技正式迈入量产时代。据科普中国介绍，脑机接口是指在大脑与设备 之间建立直接连接，实现大脑与外部世界的信息交换与控制。这一技术让人们用意念操控设备成为可 能。 开源证券认为，脑机接口行业正处于技术突破、政策支持、机器人生态协同预期等多重因素驱动下的高 增蓄势期，根据Precedence Research数据，预计到2034年全球脑机接口市场规模将增长到约124亿美元， 2025-2034年CAGR为17%。在近期Neuralink规模化量产预期和技术突破的催化下，A股脑机接口相关标 的也有望受益。 国开证券指出，近期医药板块整体热点和活跃度相对较低，脑机接口领域相关进展市场关注度提升。 ...